Eidos Therapeutics Presents Data From Its Phase 1 Clinical Trial Of AG10 At The 22nd Annual Scientific Meeting Of The Heart Failure Society Of America

Monday, September 17, 2018 1 min read

Key Takeaway: Eidos Therapeutics Presents Data From Its Phase 1 Clinical Trial Of AG10 At The 22nd Annual Scientific Meeting Of The Heart Failure Society Of America

Full Press Release Details

Eidos Therapeutics Presents Data From Its Phase 1 Clinical Trial Of AG10 At The 22nd Annual Scientific Meeting Of The Heart Failure Society Of America.

FDA Calendar

BPW Portfolio

Historical FDA Calendar

Market Movers

Biotech Earning Calendar

Historical PDUFA Dates

PDUFA Calendar

Conference Calendar

IPO

Catalyst Sync™

Hedge Fund Screener

Company Screener

All Stocks Holdings

Heat-Map

Inside Trades

Biotech Analyst Ratings

M&A Tracker

News

Blogs

Modality Leaderboard

Discord

User Guide

Biotech Investing 101

Recent Updates

Recently added Catalysts

Full Press Release Details